Sana Biotechnology
Price & Volume
Stats
See more52W Range | $1.55-$12 |
Market Cap | $368.3M |
Shares Short | 35M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.40 |
News
See moreYahoo Finance • 2 months ago
Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now
Yahoo Finance • 4 months ago
Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
Yahoo Finance • last year
Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System
Yahoo Finance • last year
Sana Biotechnology to Present at November and December 2023 Investor Conferences
About
CEO | Dr. Steven D. Harr M.D. |
CFO | Ms. Susan Wyrick |
Address | 188 East Blaine Street, Seattle, WA, United States, 98102 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 328 |
